Checkpoint Genetics Pharmaceuticals, Inc., Re-Named InterNatural Pharmaceuticals, Inc. Files Form 10SB12G on June 15, 2001.Business Editors, Health/Medical Writers LOS ANGELES--(BW HealthWire)--Sept. 19, 2001 Checkpoint Genetics Pharmaceuticals, Inc., re-named InterNatural Pharmaceuticals, Inc. (Pink Sheets: INAT INAT Institut National Agronomique de Tunisie (Tunisia) INAT Network Architecture for Intelligent Routing formerly CKPT CKPT Checkpoint CKPT Cockpit ) files Form 10SB12G on June 15, 2001. For a complete copy of the Form 10SB12G filing, please log in the company website, www.inat-pharma-com and look for the relevant press release or a link to freeEDGAR.com. InterNatural Pharmaceuticals, Inc. has established principal equity investments in its subsidiaries to represent the parent company's focus in biotechnology and pharmaceutical products that result from these developments. The press release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Expression of future goals and similar expressions reflecting something other than historical fact involve risks and uncertainties. The actual results the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion